Canadian Patients’ Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys

Background: Patients with psoriasis of all severities employ topical treatment, either alone or in combination. Promoting Patient Engagement at the Leading Edge of Topical Psoriasis Treatment (PROPEL) surveyed Canadian dermatologists and their patients about their attitudes toward topical care. Obje...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cutaneous medicine and surgery 2018-09, Vol.22 (5), p.464-471
Main Authors: Vender, Ronald, Gooderham, Melinda J., Guenther, Lyn C., Kyritsis, Dimitrios, Rao, Jaggi, Kowalczyk, Alice, Ashkenas, John
Format: Article
Language:English
Subjects:
Administration, Topical
Adult
Attitude to Health
Cross-Sectional Studies
Dermatologic Agents - administration & dosage
Dermatologic Agents - therapeutic use
Dermatology
Female
Humans
Male
Medication Adherence - statistics & numerical data
Patient compliance
Patient Preference - statistics & numerical data
Patients
Practice Patterns, Physicians' - statistics & numerical data
Pruritus
Psoriasis
Psoriasis - drug therapy
Psoriasis - epidemiology
Psoriasis - physiopathology
Psoriasis - psychology
Sleep Wake Disorders
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Patients with psoriasis of all severities employ topical treatment, either alone or in combination. Promoting Patient Engagement at the Leading Edge of Topical Psoriasis Treatment (PROPEL) surveyed Canadian dermatologists and their patients about their attitudes toward topical care. Objectives: To identify gaps between patients and dermatologists regarding the burden of psoriasis, the burden of treatment, and priorities for topical care to Canadian patients with psoriasis. Methods: Two parallel surveys explored patient attitudes toward psoriasis and their experience with topical care, as expressed by patients or as perceived by their dermatologists. A third survey, addressed to patients, included additional questions regarding treatment adherence to current topical treatment regimens. Results: PROPEL dermatologists underestimated the burden associated with psoriatic itch. Otherwise, they were well aligned with patients’ views, including their preference for maintaining topical care of their psoriasis over other treatment modalities, the nature of good psoriasis control, and desirable features of topical medications. Despite holding generally positive views of topical therapy, many patients self-identified as poorly adherent. Conclusions: Long-term adherence to psoriasis topical care remains a challenge. Formulations with improved acceptability might help patients maintain good adherence.
ISSN:1203-4754
1615-7109
DOI:10.1177/1203475418773736